Eliza A Hawkes

Loading... 2 0 20 0 false
Credit Name
Eliza A Hawkes
Full Name
Hawkes, Eliza A
 
 
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Opat, Stephen

Results 1-7 of 7 (Search time: 0.004 seconds).

Publication YearTitleAuthor(s)
1Apr-2023Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry.Nguyen, James; Wellard, Cameron; Chung, Eliza; Cheah, Chan Y; Dickinson, Michael; Doo, Nicole Wong; Keane, Colm; Talaulikar, Dipti; Berkahn, Leanne; Morgan, Susan; Hamad, Nada; Cochrane, Tara; Johnston, Anna M; Forsyth, Cecily; Opat, Stephen; Barraclough, Allison ; Mutsando, Howard; Ratnasingam, Sumita; Giri, Pratyush; Wood, Erica M; McQuilten, Zoe K; Hawkes, Eliza A 
2Jun-2022Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma.Wong, Jonathan; Gruber, Emily; Maher, Belinda; Waltham, Mark; Sabouri-Thompson, Zahra; Jong, Ian; Luong, Quinton; Levy, Sidney; Kumar, Beena; Brasacchio, Daniella; Jia, Wendy; So, Joan; Skinner, Hugh; Lewis, Alexander; Hogg, Simon J; Vervoort, Stephin; DiCorleto, Carmen; Uhe, Micheleine; Gamgee, Jeanette; Opat, Stephen; Gregory, Gareth P; Polekhina, Galina; Reynolds, John; Hawkes, Eliza A ; Kailainathan, Gajan; Gasiorowski, Robin; Kats, Lev M; Shortt, Jake
315-Sep-2021The Magnolia Trial: Zanubrutinib, A Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma.Opat, Stephen; Tedeschi, Alessandra; Linton, Kim; McKay, Pamela; Hu, Bei; Chan, Henry; Jin, Jie; Sobieraj-Teague, Magdalena; Zinzani, Pier Luigi; Coleman, Morton; Thieblemont, Catherine; Browett, Peter; Ke, Xiaoyan; Sun, Mingyuan; Marcus, Robert; Portell, Craig A; Ardeshna, Kirit; Bijou, Fontanet; Walker, Patricia; Hawkes, Eliza A ; Mapp, Sally; Ho, Shir-Jing; Talaulikar, Dipti; Zhou, Ke-Shu; Co, Melannie; Li, Xiaotong; Zhou, Wenxiao; Cappellini, Massimo; Tankersley, Chris; Huang, Jane; Trotman, Judith
426-Oct-2020Caution in Expanding the Use of Abbreviated R-CHOP to Poor-Risk Limited-Stage DLBCL.Hawkes, Eliza A ; Opat, Stephen; Hertzberg, Mark
5Aug-2020A consensus statement on the use of biosimilar medicines in hematology in Australia.Gregory, Gareth P; Carrington, Christine; Cheah, Chan Y; Hawkes, Eliza A ; Irving, Ian M; Siderov, Jim ; Opat, Stephen
619-Sep-2019Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma.Ratnasingam, Sumita; Casan, Joshua; Shortt, Jake; Hawkes, Eliza A ; Gilbertson, Michael; McQuilten, Zoe; Grigoriadis, George; Htun, Kay Thwe; Htet, Swe Myo; Campbell, Philip; Chai, Khai Li; Quach, Hang; Patil, Sushrut; Opat, Stephen
720-Dec-2017Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life Support.Opat, Stephen; Hawkes, Eliza A